| Identification of ALK as a major familial neuroblastoma predisposition gene YP Mossé, M Laudenslager, L Longo, KA Cole, A Wood, EF Attiyeh, ... Nature 455 (7215), 930-935, 2008 | 1625 | 2008 |
| Clinical impact of the NKp30/B7-H6 axis in high-risk neuroblastoma patients M Semeraro, S Rusakiewicz, V Minard-Colin, NF Delahaye, D Enot, ... Science translational medicine 7 (283), 283ra55-283ra55, 2015 | 152 | 2015 |
| Targeting macrophages as a potential therapeutic intervention: impact on inflammatory diseases and cancer M Ponzoni, F Pastorino, D Di Paolo, P Perri, C Brignole International journal of molecular sciences 19 (7), 1953, 2018 | 150 | 2018 |
| MYCN On cogene Amplification in Neuroblastom a Is Associated VVith VVorse Prognosis, Except in Stage 4s: The Italian Experience VVith 295 Children GP Tonini, L Boni, A Pession, D Rogers Journal of clinical oncology 15 (1), 85-93, 1997 | 137 | 1997 |
| A novel liposomal Clodronate depletes tumor-associated macrophages in primary and metastatic melanoma: Anti-angiogenic and anti-tumor effects F Piaggio, V Kondylis, F Pastorino, D Di Paolo, P Perri, I Cossu, F Schorn, ... Journal of Controlled Release 223, 165-177, 2016 | 103 | 2016 |
| Combined targeting of perivascular and endothelial tumor cells enhances anti-tumor efficacy of liposomal chemotherapy in neuroblastoma M Loi, S Marchiò, P Becherini, D Di Paolo, M Soster, F Curnis, C Brignole, ... Journal of controlled release 145 (1), 66-73, 2010 | 90 | 2010 |
| Combined therapeutic effects of vinblastine and rapamycin on human neuroblastoma growth, apoptosis, and angiogenesis D Marimpietri, C Brignole, B Nico, F Pastorino, A Pezzolo, F Piccardi, ... Clinical Cancer Research 13 (13), 3977-3988, 2007 | 88 | 2007 |
| Therapeutic targeting of TLR9 inhibits cell growth and induces apoptosis in neuroblastoma C Brignole, D Marimpietri, DD Paolo, P Perri, F Morandi, F Pastorino, ... Cancer research 70 (23), 9816-9826, 2010 | 86 | 2010 |
| Neuroblastoma-targeted nanoparticles entrapping siRNA specifically knockdown ALK D Di Paolo, C Brignole, F Pastorino, R Carosio, A Zorzoli, M Rossi, M Loi, ... Molecular Therapy 19 (6), 1131-1140, 2011 | 77 | 2011 |
| Selective therapeutic targeting of the anaplastic lymphoma kinase with liposomal siRNA induces apoptosis and inhibits angiogenesis in neuroblastoma D Di Paolo, C Ambrogio, F Pastorino, C Brignole, C Martinengo, ... Molecular Therapy 19 (12), 2201-2212, 2011 | 76 | 2011 |
| A proof-of-concept for epigenetic therapy of tissue fibrosis: inhibition of liver fibrosis progression by 3-deazaneplanocin A M Zeybel, S Luli, L Sabater, T Hardy, F Oakley, J Leslie, A Page, ... Molecular Therapy 25 (1), 218-231, 2017 | 74 | 2017 |
| Recent advances in the developmental origin of neuroblastoma: an overview M Ponzoni, T Bachetti, MV Corrias, C Brignole, F Pastorino, E Calarco, ... Journal of Experimental & Clinical Cancer Research 41 (1), 92, 2022 | 73 | 2022 |
| PHOX2B-Mediated Regulation of ALK Expression: In Vitro Identification of a Functional Relationship between Two Genes Involved in Neuroblastoma T Bachetti, D Di Paolo, S Di Lascio, V Mirisola, C Brignole, M Bellotti, ... PloS one 5 (10), e13108, 2010 | 70 | 2010 |
| PHOX2B mutations and genetic predisposition to neuroblastoma P Perri, T Bachetti, L Longo, I Matera, M Seri, GP Tonini, I Ceccherini Oncogene 24 (18), 3050-3053, 2005 | 64 | 2005 |
| The use of the orthotopic model to validate antivascular therapies for cancer. M Loi, D Di Paolo, P Becherini, A Zorzoli, P Perri, R Carosio, M Cilli, ... International Journal of Developmental Biology 55, 2011 | 61 | 2011 |
| Tumor vascular targeted liposomal-bortezomib minimizes side effects and increases therapeutic activity in human neuroblastoma G Zuccari, A Milelli, F Pastorino, M Loi, A Petretto, A Parise, C Marchetti, ... Journal of controlled release 211, 44-52, 2015 | 60 | 2015 |
| ALK-dependent control of hypoxia-inducible factors mediates tumor growth and metastasis C Martinengo, T Poggio, M Menotti, MS Scalzo, C Mastini, C Ambrogio, ... Cancer research 74 (21), 6094-6106, 2014 | 60 | 2014 |
| Enhanced anti-tumor and anti-angiogenic efficacy of a novel liposomal fenretinide on human neuroblastoma D Di Paolo, F Pastorino, G Zuccari, I Caffa, M Loi, D Marimpietri, ... Journal of controlled release 170 (3), 445-451, 2013 | 51 | 2013 |
| Genetic predisposition to familial neuroblastoma: identification of two novel genomic regions at 2p and 12p L Longo, E Panza, F Schena, M Seri, M Devoto, G Romeo, C Bini, ... Human heredity 63 (3-4), 205-211, 2007 | 49 | 2007 |
| Weak linkage at 4p16 to predisposition for human neuroblastoma P Perri, L Longo, R Cusano, CM McConville, SA Rees, M Devoto, ... Oncogene 21 (54), 8356-8360, 2002 | 46 | 2002 |
